ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

BSA Strikes Down NCI Tissue Bank Plan, Calls for Audit of caBIG

March 11, 2011

Duke Retraction May Alter IOM Investigation; Review Panel Membership Announced

November 5, 2010

NIH Funding Strategies, UICC Fellowships

December 4, 1992

In Congress: HHS Hasn’t Identified Another Source For NIH Increase If Tobacco Bill Not Passed: Shalala

March 6, 1998

Supplements Reduce Deaths In NCI Studies In China “JNCI”

September 17, 1993

In Brief: ACS Appoints Directors For Government Relations And Grassroots Development

April 25, 1997